Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biopharmaceutical company. The Company’s principal activities are research, drug development and clinical trials of psilocybin products. The Company offers healthcare professionals a variety serotonin-modulating medications by developing drug families derived from Psilocybin and MDMA. The Company is developing several prodrug families, beginning with a psilocybin-derived smoking cessation drug undergoing a NIDA-funded trial at Johns Hopkins University. It is also developing MYCO-006, short-acting chemical analogs derived from MDMA for treating various conditions, including anxiety and pain. It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Post by CarbonBigFooton Dec 04, 2017 7:38am

60 Views

Post# 27082980

Shorts are dicking around in the wrong sector!

You shorts are totally in the wrong sector. Go pick a couple of silver companies with properties in Peru and Mexico and short those. You are trying to short a rocking sector and you will pay the price. Don’t forget to call your credit card company today and get them to raise the ceiling on your limit. You’re going to need the cash!

Bullboard Posts

First Nations contributions attract investor interest